Advantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics Testing

Advantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics Testing

As recognised by the National Institutes of Health (NIH) Precision Medicine Initiative (PMI), microarray technology currently provides a rapid, inexpensive means of identifying large numbers of known genomic variants or gene transcripts in experimental and clinical settings. However new generation s...

Full description

Bibliographic Details
Main Authors: Al Shahandeh, Daniel M. Johnstone, Joshua R. Atkins, Jean-Marie Sontag, Moones Heidari, Nilofar Daneshi, Elvis Freeman-Acquah, Elizabeth A. Milward
Format: Article
Language:English
Published: MDPI AG 2016-05-01
Series:Microarrays
Subjects:
microarray
next-generation sequencing
pharmacogenomics
personalized healthcare
Online Access:http://www.mdpi.com/2076-3905/5/2/12

Internet

http://www.mdpi.com/2076-3905/5/2/12

Similar Items